95 related articles for article (PubMed ID: 23334799)
1. Reply: To PMID 22833233.
Samson M; Janikashvili N; Martin L; Audia S; Bonnotte B
Arthritis Rheum; 2013 Apr; 65(4):1134-5. PubMed ID: 23334799
[No Abstract] [Full Text] [Related]
2. Treg cells in giant cell arteritis: might they be another target for adjuvant treatment? Comment on the article by Samson et al. Reply.
Samson M; Bonnotte B
Arthritis Rheum; 2013 Jan; 65(1):289-90. PubMed ID: 23001840
[No Abstract] [Full Text] [Related]
3. Treg cells in giant cell arteritis: might they be another target for adjuvant treatment? Comment on the article by Samson et al.
Fernández-Fernández FJ
Arthritis Rheum; 2013 Jan; 65(1):289. PubMed ID: 23001860
[No Abstract] [Full Text] [Related]
4. Functionally relevant treg cells are present in giant cell arteritis lesions: comment on the article by Samson et al.
Corbera-Bellalta M; Planas-Rigol E; Espígol-Frigolé G; Lozano E; Cid MC
Arthritis Rheum; 2013 Apr; 65(4):1133-4. PubMed ID: 23334937
[No Abstract] [Full Text] [Related]
5. Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis.
Samson M; Audia S; Fraszczak J; Trad M; Ornetti P; Lakomy D; Ciudad M; Leguy V; Berthier S; Vinit J; Manckoundia P; Maillefert JF; Besancenot JF; Aho-Glele S; Olsson NO; Lorcerie B; Guillevin L; Mouthon L; Saas P; Bateman A; Martin L; Janikashvili N; Larmonier N; Bonnotte B
Arthritis Rheum; 2012 Nov; 64(11):3788-98. PubMed ID: 22833233
[TBL] [Abstract][Full Text] [Related]
6. CD8 lymphocytes in polymyalgia rheumatica and giant cell arteritis: a reply.
Arnold MH; Pitzalis C; Corrigall VM; Panayi GS
Clin Exp Rheumatol; 1994; 12(2):228. PubMed ID: 8039296
[No Abstract] [Full Text] [Related]
7. HLA antigens in patients with giant cell arteritis and polymyalgia rheumatica.
Hunder GG; Taswell HF; Pineda AA; Elveback LR
J Rheumatol; 1977; 4(3):321-3. PubMed ID: 926109
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of polymyalgia rheumatica.
Guggino G; Ferrante A; Macaluso F; Triolo G; Ciccia F
Reumatismo; 2018 Mar; 70(1):10-17. PubMed ID: 29589398
[TBL] [Abstract][Full Text] [Related]
9. HLA-DR locus antigens in polymyalgia rheumatica and giant cell arteritis.
Calamia KT; Moore SB; Elveback LR; Hunder GG
J Rheumatol; 1981; 8(6):993-6. PubMed ID: 6948960
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR antigens in polymyalgia rheumatica and giant cell arteritis.
Gouet D; Alcalay D; Azais I; Alcalay M; Becq-Giraudon B; Sudre Y; Bontoux D
J Rheumatol; 1985 Jun; 12(3):627-8. PubMed ID: 3862847
[No Abstract] [Full Text] [Related]
11. Anti-neutrophil cytoplasm antibodies in giant cell arteritis and polymyalgia rheumatica.
Meyer O; De Bandt M; Haim T; Kahn MF
Ann Med Interne (Paris); 1992; 143(7):476. PubMed ID: 1300870
[No Abstract] [Full Text] [Related]
12. Circulating T cell subtypes in polymyalgia rheumatica and giant cell arteritis: variation in the percentage of CD8+ cells with prednisolone treatment.
Panayi GS
Ann Rheum Dis; 1994 Apr; 53(4):283. PubMed ID: 8203964
[No Abstract] [Full Text] [Related]
13. Polymyalgia rheumatica and giant cell arteritis: histocompatibility typing and hepatitis-B infection studies.
Bridgeford PH; Lowenstein M; Bocanegra TS; Vasey FB; Germain BF; Espinoza LR
Arthritis Rheum; 1980 Apr; 23(4):516-8. PubMed ID: 7370065
[No Abstract] [Full Text] [Related]
14. Lack of consistent peripheral blood lymphocyte transformation responses in polymyalgia rheumatica and giant cell arteritis.
Jones JG; Park JR; Hazelman BL; Ward M; Bulgen DY
J Rheumatol; 1980; 7(6):891-4. PubMed ID: 7205827
[TBL] [Abstract][Full Text] [Related]
15. [Dysimmune manifestations in Horton's disease and polymyalgia rheumatica].
De Coninck P; Büschges B; Thouvenin T; Auxenfants E; Bouton Y; Plouvier B
Presse Med; 1989 Sep; 18(29):1435. PubMed ID: 2529526
[No Abstract] [Full Text] [Related]
16. In vitro lymphocyte cytotoxicity to cultured human arterial smooth muscle cells in patients with giant cell arteritis and polymyalgia rheumatica.
Park JR; Jones JG; Hazleman BL
J Rheumatol; 1981; 8(1):125-8. PubMed ID: 7218240
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to intermediate filaments in polymyalgia rheumatica/giant cell arteritis: do they reflect the underlying disease activity rather than the acute phase response?
Monteagudo I; Corrigall V; Panayi GS; Pountain G; Hazleman BL
Ann Rheum Dis; 1994 Feb; 53(2):150. PubMed ID: 8129464
[No Abstract] [Full Text] [Related]
18. First international conference on polymyalgia rheumatica and giant cell arteritis, Prato, Italy. May 25-26, 1999.
Schirmer M; Calamia KT; Salvarani C
J Rheumatol; 2000 Jul; 27(7):1801-3. PubMed ID: 10914874
[No Abstract] [Full Text] [Related]
19. Polymyalgia rheumatica and giant cell arteritis: circulating immune complexes.
Espinoza LR; Bridgeford P; Lowenstein M; Bocanegra TS; Vasey FB; Germain BF
J Rheumatol; 1982; 9(4):556-60. PubMed ID: 6215486
[TBL] [Abstract][Full Text] [Related]
20. Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.
Burkel M; Arndt F; Schirmer JH; Moosig F; Holle JU
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):94-97. PubMed ID: 27974093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
